Latest News

January 19, 2012
UCSF scientists have discovered the unexpected way in which a key cell of the immune system prepares for battle. The finding, they said, offers insight into the processes that take place within these cells and could lead to strategies for treating conditions from spinal cord injury to cancer.
November 09, 2011
UCSF Medical Center performs a lower-risk cardiac procedure to treat coronary blockage that goes through the radial artery in a patient's arm, an uncommon practice in the U.S., where more than 95 percent of heart catheterizations are performed through the femoral artery in the patient’s leg.
September 19, 2011
A UCSF study holds clues to why an emerging clinical trials option for heart attack patients has not been as successful as anticipated. Treatment of human hearts with bone marrow cells has led to limited to no success in improving their heart function even though a similar method has been much more effective in rodents.
August 03, 2011
A new and simple risk score may aid physicians in gauging the likelihood that a common drug will cause a hemorrhagic stroke or other major bleeding in patients with atrial fibrillation, potentially allowing wider but safer use of the effective drug.
July 06, 2011
UCSF Medical Center has reduced hospital readmissions for older heart failure patients by nearly a third, thanks to a program designed to identify ways for hospitals to improve patients' transitions to their homes.
June 20, 2011
Outcomes of bypass surgery to repair blocked arteries in the legs tend to be better in the roughly one-in-five people who have inherited a specific genetic variation from both parents, according to a study presented at the late-breaking clinical trials session of the Vascular Annual Meeting in Chicago on June 18, 2011.
May 06, 2011
The ongoing controversy surrounding the safety of using TASER® electrical stun guns took a new turn today when a team of cardiologists at the University of California, San Francisco announced findings suggesting that much of the current TASER®-related safety research may be biased due to ties to the devices’ manufacturer, TASER International, Inc.
May 04, 2011
Blending state-of-the art technology and cutting-edge design, UCSF’s new cardiovascular research building at Mission Bay integrates basic and clinical research to address important questions in cardiovascular biology and disease. 
March 01, 2011
Scientists at the UCSF Cardiovascular Research Institute have discovered how a change in growth hormone activity in mice leads to fatty liver disease, a condition whose human counterpart is of rising concern worldwide.
December 20, 2010
’Tis the season for temptations, with holiday dinners and treats nearly everywhere we turn. So stick a fork into these 10 tips from the UCSF Center for Prevention of Heart and Vascular Disease.

Pages